Figure 1: Association of BMI with receptor status and molecular subtype in breast cancer patients at time of diagnosis. BMI among all patients, premenopausal cases, and postmenopausal cases in relation to (a) ER, (b) PR, (c) HER2, and (d) molecular subtype. Bars represent mean BMI value ± SEM. BMI, body mass index; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor.